RaySearch Laboratories AB: Financial and Strategic Updates
RaySearch Laboratories AB, a prominent player in the health care technology sector, has recently been in the spotlight due to several key developments. The company, which specializes in developing software solutions for cancer treatment, is listed on the Swedish Stock Exchange and trades in SEK. As of May 29, 2025, the close price of RaySearch Laboratories AB was 310.5 SEK, with a 52-week high of 318.5 SEK on May 15, 2025, and a low of 123.6 SEK on August 5, 2024. The company’s market capitalization stands at 10,463,460,900 SEK, with a price-to-earnings ratio of 55.2914.
Upcoming Financial Results
RaySearch Laboratories AB is set to release its quarterly financial results for the quarter ending June 30, 2025, on August 8, 2025. Analysts have projected an earnings per share (EPS) of 1.11 SEK, a decrease from the 1.79 SEK reported in the same quarter the previous year. Additionally, three analysts anticipate a slight 0.42% reduction in revenue, expecting it to reach 317 million SEK.
Strategic Partnerships and Expansions
In a significant development, RaySearch Laboratories AB has secured a contract with AKSM/Oncology for its RayCare and RayStation systems at a new cancer center in San Luis Obispo, California. The center, named Advanced Radiation Therapeutics (ART), is being developed in collaboration with Urology Associates of The Central Coast and is expected to open in March 2026. ART will utilize RaySearch’s software alongside Varian’s TrueBeam linear accelerators to offer advanced radiation therapy techniques. This order was received in the second quarter of 2025.
Stock Market Performance
RaySearch Laboratories AB has been part of a broader positive trend on the Stockholm Stock Exchange, where 18 companies have reached new 52-week highs as of July 21, 2025. This reflects a favorable market sentiment despite geopolitical tensions in the Middle East, which have not significantly impacted the stock performance of smaller companies.
Conclusion
RaySearch Laboratories AB continues to strengthen its position in the medical technology industry through strategic partnerships and technological advancements. The upcoming financial results will provide further insights into the company’s performance and future prospects.